Daily Target 2X Long RCAT ETF EBIT

The latest EBIT for RCAX is $-14M as of July 2016. That compares with $-26M in the prior-year period — up 46.6% year over year. That is below the sector sector average of $2.6T. Investors often review this figure alongside Daily Target 2X Long RCAT ETF's historical trend and sector peers before judging valuation or financial health.

Over the past year, RCAX's EBIT moved from $-26M to $-14M — a 46.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Daily Target 2X Long RCAT ETF's operating scale or balance-sheet position.

Against its sector companies, RCAX currently prints $-14M for EBIT, while the sector average sits near $2.6T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Daily Target 2X Long RCAT ETF's growth, margins, and balance sheet.

A EBIT figure of $-14M for RCAX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.6T. Explore the charts below for those layers of context.

After noting RCAX's EBIT ($-14M), review year-over-year change from $-26M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.